We are live on
!
Find out more
LSV Asset Management Portfolio holdings
AUM
$55.1B
1-Year Est. Return
45.38%
This Fund
S&P 500
This Quarter
Est. Return
+5.41%
1 Year Est. Return
+45.38%
3 Year Est. Return
+99.45%
5 Year Est. Return
+122.42%
10 Year Est. Return
+379.58%
AUM
$60.6B
AUM Growth
+$4.48B
(+8%)
Cap. Flow
+$1.95B
Cap. Flow
% of AUM
3.22%
Top 10 Holdings %
Top 10 Hldgs %
15.67%
Holding
1,047
New
35
Increased
381
Reduced
346
Closed
48
Avg Time Held
10.9
quarters
Top 10 Avg Time Held
11.5
quarters
Top 20 Avg Time Held
9.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
J.M. Smucker
SJM
|
+$164M |
| 2 |
BorgWarner
BWA
|
+$130M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
+$123M |
| 4 |
Gilead Sciences
GILD
|
+$107M |
| 5 |
CVS Health
CVS
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bunge Global
BG
|
+$176M |
| 2 |
Qualcomm
QCOM
|
+$163M |
| 3 |
Boeing
BA
|
+$87.2M |
| 4 |
American Financial Group
AFG
|
+$56.1M |
| 5 |
Ryder
R
|
+$50.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.73% |
| 2 | Technology | 13.69% |
| 3 | Healthcare | 13.65% |
| 4 | Industrials | 10.87% |
| 5 | Consumer Discretionary | 10.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Johnson & Johnson
JNJ
$636B
| $1.28B | 2.11% |
9,818,497
-215,526
| -2% | -$28.6M |
2013 Q2
17 quarters
|
|
2
Pfizer
PFE
$162B
| $1.23B | 2.03% |
36,302,789
+1,230,336
| +4% | +$39.5M |
2013 Q2
17 quarters
|
|
3
JPMorgan Chase
JPM
$890B
| $1.18B | 1.94% |
12,345,368
-23,383
| -0.2% | -$2.16M |
2013 Q2
17 quarters
|
|
4
Citigroup
C
$221B
| $983M | 1.62% |
13,512,104
+491,832
| +4% | +$33.6M |
2013 Q2
17 quarters
|
|
5
Cisco
CSCO
$455B
| $941M | 1.55% |
27,974,705
+521,245
| +2% | +$16.6M |
2013 Q2
17 quarters
|
|
6
Intel
INTC
$534B
| $909M | 1.5% |
23,866,908
+900,658
| +4% | +$32M |
2013 Q2
17 quarters
|
|
7
AT&T
T
$154B
| $806M | 1.33% |
27,233,155
-111,813
| -0.4% | -$3.17M |
2013 Q2
17 quarters
|
|
8
Bank of America
BAC
$381B
| $772M | 1.27% |
30,452,443
+1,849,749
| +6% | +$44.9M |
2013 Q2
17 quarters
|
|
9
Valero Energy
VLO
$125B
| $710M | 1.17% |
9,233,881
+157,022
| +2% | +$10.8M |
2013 Q2
17 quarters
|
|
10
ExxonMobil
XOM
$706B
| $697M | 1.15% |
8,505,274
-186,854
| -2% | -$14.8M |
2013 Q2
17 quarters
|
|
|
11
Boeing
BA
$149B
| $669M | 1.1% |
2,632,931
-373,927
| -12% | -$87.2M |
2013 Q2
17 quarters
|
|
12
Amgen
AMGN
$225B
| $668M | 1.1% |
3,580,310
+119,621
| +3% | +$21.2M |
2013 Q2
17 quarters
|
|
13
Verizon
VZ
$177B
| $662M | 1.09% |
13,385,486
+556,193
| +4% | +$26.2M |
2013 Q2
17 quarters
|
|
14
Public Service Enterprise Group
PEG
$35.2B
| $652M | 1.08% |
14,101,249
+304,699
| +2% | +$13.8M |
2013 Q2
17 quarters
|
|
15
Merck
MRK
$359B
| $637M | 1.05% |
10,433,823
+156,068
| +2% | +$9.46M |
2013 Q2
17 quarters
|
|
16
AbbVie
ABBV
$496B
| $608M | 1% |
6,842,773
+214,187
| +3% | +$16.3M |
2013 Q2
17 quarters
|
|
17
Chevron
CVX
$422B
| $587M | 0.97% |
4,999,951
+78,200
| +2% | +$8.54M |
2013 Q2
17 quarters
|
|
18
Elevance Health
ELV
$91.3B
| $514M | 0.85% |
2,707,528
-5,261
| -0.2% | -$1M |
2013 Q2
17 quarters
|
|
|
19
CVS Health
CVS
$111B
| $493M | 0.81% |
6,063,855
+1,180,964
| +24% | +$93.4M |
2013 Q2
17 quarters
|
|
20
Allstate
ALL
$58.9B
| $489M | 0.81% |
5,325,708
+47,058
| +0.9% | +$4.28M |
2013 Q2
17 quarters
|
|
21
Travelers Companies
TRV
$77.6B
| $488M | 0.8% |
3,982,655
-69,680
| -2% | -$8.7M |
2013 Q2
17 quarters
|
|
22
FedEx
FDX
$68.8B
| $478M | 0.79% |
2,119,586
+229,586
| +12% | +$48.9M |
2013 Q2
17 quarters
|
|
23
FirstEnergy
FE
$26.2B
| $457M | 0.75% |
14,821,910
+383,279
| +3% | +$12.1M |
2014 Q1
14 quarters
|
|
24
Everest Group
EG
$14.3B
| $452M | 0.75% |
1,980,297
+21,860
| +1% | +$5.51M |
2013 Q2
17 quarters
|
|
25
Regions Financial
RF
$23.4B
| $446M | 0.74% |
29,313,283
+1,741,225
| +6% | +$25M |
2013 Q2
17 quarters
|
|
Similar funds
HF
LSV Asset Management's Q3 2017 Portfolio in Review
As of Q3 2017, LSV Asset Management held 1,047 positions worth $60.6B, up 8% from $56.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
LSV Asset Management deployed $1.95B of net new capital in Q3 2017, opening 35 new positions and adding to 381 existing holdings. Its largest new stake was J.M. Smucker: 1,437,276 shares worth $151M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 25% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bunge Global, an estimated $176M trimmed.
- LSV Asset Management's largest Q3 2017 buy was J.M. Smucker: 1,437,276 shares worth $151M.
- LSV Asset Management added most to BorgWarner in Q3 2017, an estimated $130M increase.
- LSV Asset Management's biggest Q3 2017 reduction was Bunge Global, cutting an estimated $176M.
- LSV Asset Management fully exited Opus Bank Common Stock in Q3 2017, selling an estimated $11.3M.
- LSV Asset Management's ten largest holdings make up 16% of its $60.6B portfolio in Q3 2017.
- LSV Asset Management opened 35 new positions and closed 48 in Q3 2017.
- LSV Asset Management's portfolio value rose 8% quarter-over-quarter to $60.6B.
Based on LSV Asset Management's 13F filing for Q3 2017, filed 13 Nov 2017.